Genetic variation in IGF1, IGF-1R, IGFALS, and IGFBP3 in breast cancer survival among Chinese women: A report from the Shanghai Breast Cancer Study

Breast Cancer Research and Treatment

Volumn 104, Issue 3, 2007, Pages 309-319

  Deming, Sandra L ^a   Ren, Zefang ^a,b   Wen, Wanqing ^a   Shu, Xiao Ou ^a   Cai, Qiuyin ^a   Gao, Yu Tang ^c   Zheng, Wei ^a,d  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b Guangzhou Center for Disease Prevention and Control   (China)

^c SHANGHAI CANCER INSTITUTE   (China)

^d VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Breast; Cancer; IGF; Polymorphisms; Survival

Indexed keywords

BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; DEMOGRAPHY; DNA ISOLATION; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; WOMEN'S HEALTH;

EID: 34547795168     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9420-8     Document Type: Article

References (38)

1. Macaulay VM (1992) Insulin-like growth factors and cancer. Br J Cancer 65:311-320
2. Daughaday WH, Rotwein P (1989) Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 10:68-91
3. Renehan AG, Zwahlen M, Minder C et al (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346-1353
4. Raile K, Hille R, Laue S et al (2003) Insulin-like growth factor I (IGF-I) stimulates proliferation but also increases caspase-3 activity, Annexin-V binding, and DNA-fragmentation in human MG63 osteosarcoma cells: co-activation of pro- and anti-apoptotic pathways by IGF-I. Horm Metab Res 35:786-793
5. Raile K, Berthold A, Banning U et al (2003) IGFs, basic FGF, and glucose modulate proliferation and apoptosis induced by IFN gamma but not by IL-1beta in rat INS-1E beta-cells. Horm Metab Res 35:407-414
6. LeRoith D, Werner H, Beitner-Johnson D et al (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 16:143-163
7. Werner H, Adamo M, Roberts CT Jr et al (1994) Molecular and cellular aspects of insulin-like growth factor action. Vitam Horm 48:1-58
8. Canzian F, McKay JD, Cleveland RJ et al (2006) Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study. Br J Cancer 94:299-307
9. Malin A, Dai Q, Yu H et al (2004) Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma. Cancer 100:694-700
10. Bohlke K, Cramer DW, Trichopoulos D et al (1998) Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 9:570-573
11. Hankinson SE, Willett WC, Colditz GA et al (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396
12. Muti P, Quattrin T, Grant BJ et al (2002) Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 11:1361-1368
13. Peyrat JP, Bonneterre J, Hecquet B et al (1993) Plasma insulin-like growth factor-1 (IGF-1) concentrations in human breast cancer. Eur J Cancer 29A:492-497
14. Toniolo P, Bruning PF, Akhmedkhanov A et al (2000) Serum insulin-like growth factor-I and breast cancer. Int J Cancer 88:828-832
15. Allen NE, Roddam AW, Allen DS et al (2005) A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk. Br J Cancer 92:1283-1287
16. Setiawan VW, Cheng I, Stram DO et al (2006) Igf-I genetic variation and breast cancer: the multiethnic cohort. Cancer Epidemiol Biomarkers Prev 15:172-174
17. Ren Z, Cai Q, Shu XO et al (2004) Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women. Cancer Epidemiol Biomarkers Prev 13:1290-1295
18. Krajcik RA, Borofsky ND, Massardo S et al (2002) Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer. Cancer Epidemiol Biomarkers Prev 11:1566-1573
19. Schernhammer ES, Hankinson SE, Hunter DJ et al (2003) Polymorphic variation at the -202 locus in IGFBP3: influence on serum levels of insulin-like growth factors, interaction with plasma retinol and vitamin D and breast cancer risk. Int J Cancer 107:60-64
20. Wen W, Gao YT, Shu XO et al (2005) Insulin-like growth factor-I gene polymorphism and breast cancer risk in Chinese women. Int J Cancer 113:307-311
21. Canzian F, McKay JD, Cleveland RJ et al (2005) Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study. Cancer Epidemiol Biomarkers Prev 14:2316-2325
22. Wagner K, Hemminki K, Israelsson E et al (2005) Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer. Breast Cancer Res Treat 92:133-140
23. Cleveland RJ, Gammon MD, Edmiston SN et al (2006) IGF1 CA repeat polymorphisms, lifestyle factors and breast cancer risk in the Long Island Breast Cancer Study Project. Carcinogenesis 27:758-765
24. Missmer SA, Haiman CA, Hunter DJ et al (2002) A sequence repeat in the insulin-like growth factor-1 gene and risk of breast cancer. Int J Cancer 100:332-336
25. Gao YT, Shu XO, Dai Q et al (2000) Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 87:295-300
26. Zaykin DV, Westfall PH, Young SS et al (2002) Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53:79-91
27. (2006) The comprehsive R archive network. website
28. Rasmussen SK, Lautier C, Hansen L et al (2000) Studies of the variability of the genes encoding the insulin-like growth factor I receptor and its ligand in relation to type 2 diabetes mellitus. J Clin Endocrinol Metab 85:1606-1610
29. Deal C, Ma J, Wilkin F et al (2001) Novel promoter polymorphism in insulin-like growth factor-binding protein-3: correlation with serum levels and interaction with known regulators. J Clin Endocrinol Metab 86:1274-1280
30. Al-Zahrani A, Sandhu MS, Luben RN et al (2006) IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer. Hum Mol Genet 15:1-10
31. Wang L, Habuchi T, Tsuchiya N et al (2003) Insulin-like growth factor-binding protein-3 gene -202 A/C polymorphism is correlated with advanced disease status in prostate cancer. Cancer Res 63:4407-4411
32. Pollak MN, Huynh HT, Lefebvre SP (1992) Tamoxifen reduces serum insulin-like growth factor I (IGF-I). Breast Cancer Res Treat 22:91-100
33. Stewart AJ, Johnson MD, May FE et al (1990) Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 265:21172-21178
34. Surmacz E, Bartucci M (2004) Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer. J Exp Clin Cancer Res 23:385-394
35. Vadgama JV, Wu Y, Datta G et al (1999) Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women. Oncology 57:330-340
36. Gronbaek H, Flyvbjerg A, Mellemkjaer L et al (2004) Serum insulin-like growth factors, insulin-like growth factor binding proteins, and breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev 13:1759-1764
37. Gee JM, Robertson JF, Gutteridge E et al (2005) Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. Endocr Relat Cancer 12 Suppl 1:S99-S111
38. Milewicz T, Gregoraszczuk EL, Sztefko K et al (2005) Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486). Growth Horm IGF Res 15:140-147